OTCMKTS:RBOT

Vicarious Surgical (RBOT) Stock Price, News & Analysis

Vicarious Surgical logo
$0.0010 +0.00 (+233.33%)
As of 11/20/2026 03:48 PM Eastern

About Vicarious Surgical Stock (OTCMKTS:RBOT)

Advanced

Key Stats

Today's Range
$0.00
▼
$0.21
50-Day Range
$0.00
▼
$0.26
52-Week Range
$0.00
▼
$3.66
Volume
505,793 shs
Average Volume
15,326 shs
Market Capitalization
$7.12 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Vicarious Surgical, Inc. is a technology company developing robotic-assisted surgical systems. Its principal product is the Vicarious Surgical System, a single-port robotic platform designed to enable surgeons to perform minimally invasive procedures through a small incision. The system combines miniature instruments, a high-resolution camera and digital controls intended to provide surgeons with an immersive view of the operating field and precise instrument control.

The company’s technology is aimed initially at general surgery applications, including procedures performed within the abdominal cavity. Vicarious Surgical has focused on developing a compact robotic system that can provide multi-axis instrument movement and visualization while potentially reducing the size and complexity of surgical access. Its products remain subject to regulatory review and authorization, and the company’s activities have primarily involved research, development and clinical evaluation rather than broad commercial deployment.

Vicarious Surgical was founded in 2014 and became a publicly traded company in 2021 through a business combination with D8 Holdings Corp. The company is based in Waltham, Massachusetts, and has concentrated its regulatory and development efforts in the United States. Co-founder Adam Sachs has served as the company’s chief executive officer and has been involved in guiding the development of its robotic surgery platform.

AI Generated. May Contain Errors.

Vicarious Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

RBOT MarketRank™: 
0.653759820425 of 5 stars

Vicarious Surgical scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vicarious Surgical has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Vicarious Surgical has received no research coverage in the past 90 days.

  • Read more about Vicarious Surgical's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vicarious Surgical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vicarious Surgical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vicarious Surgical has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Vicarious Surgical's valuation and earnings.
  • Percentage of Shares Shorted

    0.56% of the float of Vicarious Surgical has been sold short.
  • Short Interest Ratio / Days to Cover

    Vicarious Surgical has a short interest ratio ("days to cover") of 0.52, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vicarious Surgical has recently decreased by 44.79%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vicarious Surgical does not currently pay a dividend.

  • Dividend Growth

    Vicarious Surgical does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Vicarious Surgical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.11% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vicarious Surgical's insider trading history.
Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RBOT Stock News Headlines

Vicarious Surgical (RBOT) AI Stock Analysis
Whoops! I wasn’t supposed to share this with you yet
Traders have paid as much as $500 for technology like this. Thomas Wood of Base Camp Trading is offering his proprietary Snapback Indicator for just $7. There is no subscription and no recurring charge, and it's yours for life. The indicator is designed to help identify potential market turning points, showing when it may be time to buy, sell, or go short.tc pixel
SS Innovations names Sarah Romano as CFO
See More Headlines

RBOT Stock Analysis - Frequently Asked Questions

Vicarious Surgical's stock was trading at $2.16 at the beginning of 2026. Since then, RBOT shares have decreased by 100.0% and is now trading at $0.0010.

Vicarious Surgical Inc. (OTCMKTS:RBOT) posted its quarterly earnings data on Monday, March, 9th. The company reported ($1.65) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.37) by $0.28.

Vicarious Surgical's stock reverse split on Thursday, June 13th 2024.The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Editas Medicine (EDIT), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Tesla (TSLA), Super Micro Computer (SMCI) and Aktis Oncology (AKTS).

Company Calendar

Today
11/22/2026
Next Earnings (Estimated)
11/23/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:RBOT
Previous Symbol
NYSE:RBOT
CIK
1812173
Fax
N/A
Employees
48
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($6.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.18 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-340.15%
Return on Assets
-167.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.54
Quick Ratio
1.54

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.38 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
7,124,000
Free Float
6,333,000
Market Cap
$7.12 thousand
Optionable
No Data
Beta
2.35

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:RBOT) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners